These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19260123)
1. Lung function tests in sickle cell patients. Bloom CI; Murphy K; Cummin AR Am J Hematol; 2009 May; 84(5):310; author relpy 310-1. PubMed ID: 19260123 [No Abstract] [Full Text] [Related]
2. Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease. Inamo J; Connes P; Barthélémy JC; Dan V; Coates T; Loko G Am J Hematol; 2009 May; 84(5):311-2. PubMed ID: 19260125 [No Abstract] [Full Text] [Related]
3. The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood are not. Boyd JH; Strunk RC; Morgan WJ J Pediatr; 2006 Jul; 149(1):3-4. PubMed ID: 16860112 [No Abstract] [Full Text] [Related]
4. Pulmonary hypertension of sickle cell disease: more than just another lung disease. Klings ES Am J Hematol; 2008 Jan; 83(1):4-5. PubMed ID: 17924550 [TBL] [Abstract][Full Text] [Related]
5. Sickle cell disease-associated pulmonary hypertension: a coat of many colors. McLaughlin VV; Channick R Am J Respir Crit Care Med; 2007 Jun; 175(12):1218-9. PubMed ID: 17545455 [No Abstract] [Full Text] [Related]
6. [Pulmonary complications of drepanocytemia: recent advances (author's transl)]. Mafart Y; Pieron R; Rethers C; Lesobre B Med Trop (Mars); 1978; 38(2):175-82. PubMed ID: 723562 [TBL] [Abstract][Full Text] [Related]
7. No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension. van Beers EJ; Spronk HM; Ten Cate H; Duits AJ; Brandjes DP; van Esser JW; Biemond BJ; Schnog JB; Haematologica; 2008 May; 93(5):e42-4. PubMed ID: 18450728 [No Abstract] [Full Text] [Related]
8. Pulmonary complications of sickle cell disease in adults. Ardiles T; Dark D Mo Med; 2007; 104(3):250-4. PubMed ID: 17619501 [TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular disease associated with sickle cell pulmonary hypertension. Kato GJ; Hsieh M; Machado R; Taylor J; Little J; Butman JA; Lehky T; Tisdale J; Gladwin MT Am J Hematol; 2006 Jul; 81(7):503-10. PubMed ID: 16755569 [TBL] [Abstract][Full Text] [Related]
10. Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease. Wanderer AA J Pediatr Hematol Oncol; 2009 Aug; 31(8):537-8. PubMed ID: 19636265 [No Abstract] [Full Text] [Related]
11. Pulmonary complications of sickle cell disease in children. Caboot JB; Allen JL Curr Opin Pediatr; 2008 Jun; 20(3):279-87. PubMed ID: 18475096 [TBL] [Abstract][Full Text] [Related]
13. Lung function in sickle cell disease. Koumbourlis AC Paediatr Respir Rev; 2014 Mar; 15(1):33-7. PubMed ID: 24268618 [TBL] [Abstract][Full Text] [Related]
14. Primary pulmonary hypertension and sickle cell trait. Yoder L; Tabesh E; Taguchi JT Ohio State Med J; 1975 Feb; 71(2):75-8. PubMed ID: 1128858 [No Abstract] [Full Text] [Related]
15. Reverse sequestration in a case of sickle crisis. Lee ES; Chu PC Postgrad Med J; 1996 Aug; 72(850):487-8. PubMed ID: 8796214 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis. Lonsdorfer J; Castaigne JP; Lenormand E; Otayeck A; Bogui P; Dosso Y; Cabannes R Agents Actions Suppl; 1984; 15():213-8. PubMed ID: 6592944 [No Abstract] [Full Text] [Related]